India  

Remdesivir close to EU's initial authorisation as COVID-19 treatment

Reuters India Monday, 18 May 2020
The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
0
shares
ShareTweetSavePostSend
 
Video credit: Reuters Studio - Published
News video: EU close to fast-tracking COVID-19 treatment drug

EU close to fast-tracking COVID-19 treatment drug 01:40

The head of the European Union's medicines agency, Guido Rasi, has said an initial authorization for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days. Joe Davies reports.

πŸ’‘ newsR Knowledge: Other News Mentions

Remdesivir Remdesivir Antiviral drug

Remdesivir becomes first COVID-19 drug put forward for use in the EU [Video]

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Credit: Euronews English    Duration: 00:34Published
FDA Warns Against Combining Remdesivir And Hydroxychloroquine [Video]

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir. According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir. Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.

Credit: Wochit News    Duration: 00:31Published
Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission' [Video]

Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission'

Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported making the total toll to 8102. Out of the total number of cases, 1,37,448 are active while 1,41,029 have been cured. In Maharashtra, coronavirus cases reached 94,041 including 46,086 active cases and 3,438 deaths which are highest in the country. Indian Council of Medical Research informed that there is no 'community transmission' of COVID-19 in India. Earlier on June 11, Lav Agarwal, Joint Secretary, Health Ministry, said that India's recovery rate is 49.21 per cent. A total of 52,13,140 samples have been tested in the country, including 1,51,808 in the last 24 hours, according to ICMR. One new case of COVID-19 reported in ITBP in the last 24 hours. Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.

Credit: ANI    Duration: 01:51Published
Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment [Video]

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment

Health Secretary Matt Hancock announced plans for a new trial of drug Remdesivir, a treatment originally developed to fight Ebola, which appears to shorten recovery time for people with Covid-19.

Credit: PA - Press Association STUDIO    Duration: 00:43Published

European Union European Union Economic and political union of European states

New Payment System Will Challenge Mastercard And Visa [Video]

New Payment System Will Challenge Mastercard And Visa

As many as 20 major EU banks are set to announce details for a new payments initiative in the very near future. This announcement came from Electronic Payments International. Business Insider reports the system is referred to as the Pan European Payment System Initiative (PEPSI). It will process card payments in addition to making fund transfers and mobile payments without using Mastercard's or Visa's network.

Credit: Wochit News    Duration: 00:30Published
Brexit briefing: 178 days until the end of the transition period [Video]

Brexit briefing: 178 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process. Quote from Sarah Hewin, Chief economist at Standard Chartered, speaking to the Financial Times.

Credit: PA - Press Association STUDIO    Duration: 00:48Published
Brexit briefing: 179 days until the end of the transition period [Video]

Brexit briefing: 179 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process.

Credit: PA - Press Association STUDIO    Duration: 00:50Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Rugged Individualism: ICE To Deport International Students If Universities Shift Online [Video]

Rugged Individualism: ICE To Deport International Students If Universities Shift Online

The novel coronavirus COVID-19 pandemic has forced many universities to shift to online-only courses. CNN reports the Department of Immigration and Customs Enforcement has responded swiftly. ICE announced Monday that international students will have to leave the country or risk deportation if their universities only deliver education online. Thousands of foreign students come to the US to attend universities and training programs, as well as non-academic or vocational studies.

Credit: Wochit News    Duration: 00:39Published
Oh, That's Just Great. Bubonic Plague Cases ID'd In Mongolia [Video]

Oh, That's Just Great. Bubonic Plague Cases ID'd In Mongolia

As if a global pandemic of the novel coronavirus COVID-19 weren't enough, Gizmodo reports the bubonic plague has reared its nasty head once again. Sunday, officials from Inner Mongolia revealed a shepherd has been diagnosed with bubonic plague, also known as the Black Death. At the same time, a second case has been identified in neighboring Mongolia. Both patients had had contact with a wild marmot, and both are recovering. In the region, subsistence hunting is common.

Credit: Wochit News    Duration: 00:48Published
Scientists Demand The WHO Answer A Question There's No Real Answer To Yet [Video]

Scientists Demand The WHO Answer A Question There's No Real Answer To Yet

Hundreds of scientists across the world have a burning question for the World Health Organization. According to Gizmodo, they just petitioned the WHO via an open letter with one demand. The demand is that the WHO acknowledge publicly that the novel coronavirus behind COVID-19 can be airborne. That means it can spread through the air (and linger there) via tiny aerosols emitted by the breath of infected people, not just large droplets. The letter puts the WHO in a tight spot.

Credit: Wochit News    Duration: 00:46Published
Tibetans-in-exile distribute masks, sanitizers to celebrate Dalai Lama's 85th birthday [Video]

Tibetans-in-exile distribute masks, sanitizers to celebrate Dalai Lama's 85th birthday

Tibetans-in-exile in north Indian celebrated the 85th birthday of their spiritual leader Dalai Lama on July 06. Local Tibetan NGOs, monks and others from Tibetan community gathered on the main mall road of Shimla city to distribute masks and sanitizers among the locals in streets. One of the Buddhist monks said, "Due to COVID-19, we could not have a huge celebration on Dalai Lama's 85th birthday. Tibetans feel proud to celebrate his birthday by distributing sanitizers and masks among the people here." The Dalai Lama assumed full political powers in 1950 after the Chinese invasion of Tibet in 1949. In March 1959 after the suppression of Tibetan National Uprising Dalai Lama was forced to escape into exile in India with over eighty thousand refugees. For the last over six decades Dalai Lama has been working for the promotion of peace, love and compassion.

Credit: ANI    Duration: 02:08Published

Gilead Sciences Gilead Sciences American pharmaceutical company

Gilead's remdesivir gets conditional EU clearance [Video]

Gilead's remdesivir gets conditional EU clearance

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

Credit: Reuters Studio    Duration: 00:59Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

Credit: Wochit News    Duration: 00:35Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published
Stocks rise on recovery hopes [Video]

Stocks rise on recovery hopes

U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:22Published

Guido Rasi Guido Rasi Italian micro biologist

You Might Like


Related news from verified sources

US pharma co seeks authorisation for remdesivir

A US pharmaceutical giant has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted as a...
IndiaTimes

US pharma giant seeks marketing authorisation from India for anti-viral drug remdesivir

A US pharmaceutical giant has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted as a...
IndiaTimes


Tweets about this